These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12199109)

  • 1. [The role of respiratory quinolone in treatment of respiratory tract infections: focusing on gatifloxacin].
    Kohno S; Watanabe A; Matsushima T
    Jpn J Antibiot; 2002 Jun; 55(3):247-58. PubMed ID: 12199109
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significant role of newer quinolone antimicrobials in respiratory tract infection: focused on sparfloxacin].
    Jpn J Antibiot; 1994 Oct; 47(10):1241-58. PubMed ID: 7807686
    [No Abstract]   [Full Text] [Related]  

  • 3. [Grepafloxacin (Vaxar)--innovative antibiotic for therapy of respiratory tract infections. Symposium: "Grepafloxacin--a new quinolone designed for respiratory tract infection. Lausanne/Switzerland, 25 May 1997].
    Pneumologie; 1997 Sep; 51(9 Suppl):1-4. PubMed ID: 9417540
    [No Abstract]   [Full Text] [Related]  

  • 4. Grepafloxacin in respiratory tract infections: are we ready to accept a quinolone for empirical treatment?
    Norrby SR
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():99-101. PubMed ID: 9484879
    [No Abstract]   [Full Text] [Related]  

  • 5. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two new fluoroquinolones.
    Med Lett Drugs Ther; 1992 Jun; 34(872):58-60. PubMed ID: 1317502
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic potential of the new quinolones in the treatment of lower respiratory tract infections.
    Blasi F; Tarsia P; Cosentini R; Cazzola M; Allegra L
    Expert Opin Investig Drugs; 2003 Jul; 12(7):1165-77. PubMed ID: 12831351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluoroquinolones in respiratory infections.
    Klein NC
    Semin Respir Infect; 1991 Sep; 6(3):131-5. PubMed ID: 1754733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the fluoroquinolones in primary care practice.
    Harding GK
    Clin Invest Med; 1989 Feb; 12(1):71-3. PubMed ID: 2920484
    [No Abstract]   [Full Text] [Related]  

  • 10. Grepafloxacin--focus on respiratory infections.
    Geddes AM
    J Antimicrob Chemother; 1997 Dec; 40 Suppl A():1-4. PubMed ID: 9484866
    [No Abstract]   [Full Text] [Related]  

  • 11. The quinolones: decades of development and use.
    Emmerson AM; Jones AM
    J Antimicrob Chemother; 2003 May; 51 Suppl 1():13-20. PubMed ID: 12702699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of new quinolones in respiratory infections].
    Sanz Moreno J; Jiménez Rodríguez A
    Rev Clin Esp; 2000 Dec; 200(12):682-4. PubMed ID: 11234474
    [No Abstract]   [Full Text] [Related]  

  • 13. The place of quinolones in the treatment of respiratory tract infections.
    van der Meer JW
    Pharm Weekbl Sci; 1989 Aug; 11(4):132-3. PubMed ID: 2677985
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Criteria for use of ofloxacin and lomefloxacin in adult inpatients and outpatients.
    Spivey IM
    Clin Pharm; 1993 Jun; 12(6):452-8. PubMed ID: 8403817
    [No Abstract]   [Full Text] [Related]  

  • 15. Antichlamydial activities of newly developed fluoroquinolones and their potential future role in the treatment of chlamydial respiratory infections.
    Soejima R; Niki Y; Kishomoto T; Kimura M; Kubota Y
    Drugs; 1995; 49 Suppl 2():257-9. PubMed ID: 8549323
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of Baytril (Bay Vp 2674) on young turkeys with respiratory tract infections].
    Braunius WW
    Tijdschr Diergeneeskd; 1987 May; 112(9):531-3. PubMed ID: 3603541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fluoroquinolones in the treatment of respiratory infections].
    Stahlmann R
    Pneumologie; 1999 Nov; 53(11):521-9. PubMed ID: 10613068
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of adults with community-acquired respiratory tract infections: results of a multicentric clinical trial with gatifloxacin.
    Medeiros EA
    Braz J Infect Dis; 2002 Aug; 6(4):149-56. PubMed ID: 12204181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.
    Chidiac C; Mouton Y
    Infection; 1991; 19 Suppl 7():S365-71. PubMed ID: 1804785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highlights on the appropriate use of fluoroquinolones in respiratory tract infections.
    Blasi F; Tarsia P; Aliberti S; Santus P; Allegra L
    Pulm Pharmacol Ther; 2006; 19 Suppl 1():11-9. PubMed ID: 16310389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.